Salacetamide is a derivative of salicylic acid. It is analgesic, anti-inflammatory and antipyretic agent.

Salazodine (also known as SALAZOPYRIDAZINE) was studied as an antibacterial agent. It was shown that it could be active against ulcerative colitis. Experiments on animals have revealed that salazodine increased the frequency of rhythmic contractions, increased appetite and clinic recovery in animals with gastrointestinal diseases. In addition, the drug was studied as an antirheumatic agent. Information about the current use of this drug is not available.

Niometacin, an indometacin derivative, is a nonsteroidal anti-inflammatory drug.

Salazosulfathiazole was developed as a sulfonamide with the antibacterial and antirheumatic properties. Information about the current use of this drug is not available.

IVARIMOD is a hepatoprotectant.

Quinestradol is an estrogen derivative patented by Francesco Vismara Societa per Azioni and Alberto Ercol for the treatment of senile vulvovaginitis and related conditions. In preclinical trilals, quinestradol shows feminizing action in rats. A clinical trial of Quinestradol appeared to be justified since there was considerable evidence that the preparation was safe and free from side effects.

Dotefonium is the anticholinergic, spasmolytic agent.

Etasuline is a psychotherapeutic agent.

Prosulpride is an aminosulfonylbenzamide derivative with potent neuroleptic activity. Prosulpride selectively blocks the presynaptic dopaminergic receptors and antagonize apomorphine-induced stereotyped behavior, circling behavior, climbing behavior, increased motor activity and some other apomorphine-induced effects related to stimulation of postsynaptic dopaminergic receptors.